Please enable JavaScript to continue using this application.

Compare $ARTV vs $ENTA | Chartloom

Compare

$ARTV vs $ENTA

Artiva Biotherapeutics Inc · Enanta Pharmaceuticals Inc

ARTV

Artiva Biotherapeutics Inc

ENTA

Enanta Pharmaceuticals Inc

Compare $ARTV vs $ENTA

Comparing Artiva Biotherapeutics Inc and Enanta Pharmaceuticals Inc

ARTVArtiva Biotherapeutics Inc

ENTAEnanta Pharmaceuticals Inc

ARTVArtiva Biotherapeutics Inc

Market cap

$337M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

64.1%

52W performance

131.3%

FCF yield

-22.8%

ENTAEnanta Pharmaceuticals Inc

Market cap

$364M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.51x

Rev growth (TTM)

0.7%

YTD performance

-13.3%

52W performance

10.6%

FCF yield

-10.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARTV

ENTA

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

ENTA

Enanta Pharmaceuticals Inc

Market Cap

ARTV$337M

ENTA$364M

Enterprise Value

ARTV$36M

ENTA$456M

Price

ARTV$6.94

ENTA$12.50

P/E Ratio

ARTVN/A

ENTAN/A

P/S Ratio

ARTV0.00x

ENTA5.57x

EV/Sales

ARTV0.00x

ENTA6.99x

EV/EBITDA

ARTV0.00x

ENTA31.83x

P/B Ratio

ARTV0.96x

ENTA3.73x

P/FCF Ratio

ARTVN/A

ENTAN/A

EV/FCF

ARTV-0.46x

ENTA-12.36x

PEG Ratio

ARTVN/A

ENTAN/A

Forward P/E (NTM)

ARTVN/A

ENTAN/A

Forward P/S (NTM)

ARTVN/A

ENTA6.51x

Revenue (TTM)

ARTV$0

ENTA$65M

Revenue Growth (YoY)

ARTVN/A

ENTA0.7%

Forward Rev Growth

ARTV404.4%

ENTA-7.3%

Gross Margin (TTM)

ARTV0.0%

ENTA0.0%

Operating Margin (TTM)

ARTV0.0%

ENTA0.0%

EBITDA Margin (TTM)

ARTV0.0%

ENTA-82.5%

Net Margin (TTM)

ARTV0.0%

ENTA-96.9%

FCF Margin (TTM)

ARTVN/A

ENTA-56.6%

Net Income (TTM)

ARTV$-42M

ENTA$-63M

FCF (TTM)

ARTV$-77M

ENTA$-37M

EPS (TTM)

ARTV$0.00

ENTA-$2.17

ROE (TTM)

ARTV-6022.0%

ENTA-6184.0%

ROA (TTM)

ARTV-5238.0%

ENTA-2070.0%

ROIC (TTM)

ARTV-6019.0%

ENTA-2677.0%

Cash

ARTV$301M

ENTA$33M

Debt

ARTV$0

ENTA$126M

Net Cash/Debt

ARTV$301M

ENTA$-93M

Current Ratio (TTM)

ARTV24.16x

ENTA3.76x

Quick Ratio (TTM)

ARTV23.97x

ENTA3.62x

Debt/Equity (TTM)

ARTV0.00x

ENTA1.25x

Debt/Assets (TTM)

ARTV0.0%

ENTA0.0%

Interest Coverage (TTM)

ARTVN/A

ENTAN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

ENTA0.00x

Beta

ARTV5.80

ENTA0.72

52W Performance

ARTV131.3%

ENTA10.6%

YTD Performance

ARTV64.1%

ENTA-13.3%

% from 52W High

ARTV-52.2%

ENTA-27.1%

% from 52W Low

ARTV156.1%

ENTA22.5%

Asset Turnover (TTM)

ARTV0.00x

ENTA0.21x

FCF Yield (TTM)

ARTV-22.8%

ENTA-10.2%

Earnings Yield (TTM)

ARTV-12.5%

ENTA-17.4%

Dividend Yield (TTM)

ARTVN/A

ENTAN/A

Rule of 40

ARTV0.0

ENTA-55.9

EV/GP/RG

ARTVN/A

ENTAN/A

Ticker research

View ARTV research View ENTA research

Metric	ARTV Artiva Biotherapeutics Inc	ENTA Enanta Pharmaceuticals Inc
Market & Valuation
Market Cap	$337M	$364M
Enterprise Value	$36M	$456M
Price	$6.94	$12.50
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.57x
EV/Sales	0.00x	6.99x
EV/EBITDA	0.00x	31.83x
P/B Ratio	0.96x	3.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-12.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.51x
Revenue & Growth
Revenue (TTM)	$0	$65M
Revenue Growth (YoY)	N/A	0.7%
Forward Rev Growth	404.4%	-7.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-82.5%
Net Margin (TTM)	0.0%	-96.9%
FCF Margin (TTM)	N/A	-56.6%
Net Income (TTM)	$-42M	$-63M
FCF (TTM)	$-77M	$-37M
EPS (TTM)	$0.00	-$2.17
ROE (TTM)	-6022.0%	-6184.0%
ROA (TTM)	-5238.0%	-2070.0%
ROIC (TTM)	-6019.0%	-2677.0%
Financial Health
Cash	$301M	$33M
Debt	$0	$126M
Net Cash/Debt	$301M	$-93M
Current Ratio (TTM)	24.16x	3.76x
Quick Ratio (TTM)	23.97x	3.62x
Debt/Equity (TTM)	0.00x	1.25x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	0.72
52W Performance	131.3%	10.6%
YTD Performance	64.1%	-13.3%
% from 52W High	-52.2%	-27.1%
% from 52W Low	156.1%	22.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.21x
FCF Yield (TTM)	-22.8%	-10.2%
Earnings Yield (TTM)	-12.5%	-17.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-55.9
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View ENTA research

Valuation

P/S Ratio

ARTV

0.00x

ENTA

5.57x

EV/FCF

ENTA

-12.36x

ARTV

-0.46x

Growth & revenue

Revenue Growth TTM

ENTA

0.7%

Forward Revenue Growth

ARTV

404.4%

ENTA

-7.3%

Profitability & performance

Gross Margin

ARTV

0.0%

ENTA

0.0%

ROE

ARTV

-6022.0%

ENTA

-6184.0%

FCF Yield %

ENTA

-10.2%

ARTV

-22.8%

52-Week Performance

ARTV

131.3%

ENTA

10.6%

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

ENTA

Enanta Pharmaceuticals Inc

Market Cap

ARTV$337M

ENTA$364M

Enterprise Value

ARTV$36M

ENTA$456M

Price

ARTV$6.94

ENTA$12.50

P/E Ratio

ARTVN/A

ENTAN/A

P/S Ratio

ARTV0.00x

ENTA5.57x

EV/Sales

ARTV0.00x

ENTA6.99x

EV/EBITDA

ARTV0.00x

ENTA31.83x

P/B Ratio

ARTV0.96x

ENTA3.73x

P/FCF Ratio

ARTVN/A

ENTAN/A

EV/FCF

ARTV-0.46x

ENTA-12.36x

PEG Ratio

ARTVN/A

ENTAN/A

Forward P/E (NTM)

ARTVN/A

ENTAN/A

Forward P/S (NTM)

ARTVN/A

ENTA6.51x

Revenue (TTM)

ARTV$0

ENTA$65M

Revenue Growth (YoY)

ARTVN/A

ENTA0.7%

Forward Rev Growth

ARTV404.4%

ENTA-7.3%

Gross Margin (TTM)

ARTV0.0%

ENTA0.0%

Operating Margin (TTM)

ARTV0.0%

ENTA0.0%

EBITDA Margin (TTM)

ARTV0.0%

ENTA-82.5%

Net Margin (TTM)

ARTV0.0%

ENTA-96.9%

FCF Margin (TTM)

ARTVN/A

ENTA-56.6%

Net Income (TTM)

ARTV$-42M

ENTA$-63M

FCF (TTM)

ARTV$-77M

ENTA$-37M

EPS (TTM)

ARTV$0.00

ENTA-$2.17

ROE (TTM)

ARTV-6022.0%

ENTA-6184.0%

ROA (TTM)

ARTV-5238.0%

ENTA-2070.0%

ROIC (TTM)

ARTV-6019.0%

ENTA-2677.0%

Cash

ARTV$301M

ENTA$33M

Debt

ARTV$0

ENTA$126M

Net Cash/Debt

ARTV$301M

ENTA$-93M

Current Ratio (TTM)

ARTV24.16x

ENTA3.76x

Quick Ratio (TTM)

ARTV23.97x

ENTA3.62x

Debt/Equity (TTM)

ARTV0.00x

ENTA1.25x

Debt/Assets (TTM)

ARTV0.0%

ENTA0.0%

Interest Coverage (TTM)

ARTVN/A

ENTAN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

ENTA0.00x

Beta

ARTV5.80

ENTA0.72

52W Performance

ARTV131.3%

ENTA10.6%

YTD Performance

ARTV64.1%

ENTA-13.3%

% from 52W High

ARTV-52.2%

ENTA-27.1%

% from 52W Low

ARTV156.1%

ENTA22.5%

Asset Turnover (TTM)

ARTV0.00x

ENTA0.21x

FCF Yield (TTM)

ARTV-22.8%

ENTA-10.2%

Earnings Yield (TTM)

ARTV-12.5%

ENTA-17.4%

Dividend Yield (TTM)

ARTVN/A

ENTAN/A

Rule of 40

ARTV0.0

ENTA-55.9

EV/GP/RG

ARTVN/A

ENTAN/A

Ticker research

View ARTV research View ENTA research

Metric	ARTV Artiva Biotherapeutics Inc	ENTA Enanta Pharmaceuticals Inc
Market & Valuation
Market Cap	$337M	$364M
Enterprise Value	$36M	$456M
Price	$6.94	$12.50
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.57x
EV/Sales	0.00x	6.99x
EV/EBITDA	0.00x	31.83x
P/B Ratio	0.96x	3.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-12.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.51x
Revenue & Growth
Revenue (TTM)	$0	$65M
Revenue Growth (YoY)	N/A	0.7%
Forward Rev Growth	404.4%	-7.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-82.5%
Net Margin (TTM)	0.0%	-96.9%
FCF Margin (TTM)	N/A	-56.6%
Net Income (TTM)	$-42M	$-63M
FCF (TTM)	$-77M	$-37M
EPS (TTM)	$0.00	-$2.17
ROE (TTM)	-6022.0%	-6184.0%
ROA (TTM)	-5238.0%	-2070.0%
ROIC (TTM)	-6019.0%	-2677.0%
Financial Health
Cash	$301M	$33M
Debt	$0	$126M
Net Cash/Debt	$301M	$-93M
Current Ratio (TTM)	24.16x	3.76x
Quick Ratio (TTM)	23.97x	3.62x
Debt/Equity (TTM)	0.00x	1.25x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	0.72
52W Performance	131.3%	10.6%
YTD Performance	64.1%	-13.3%
% from 52W High	-52.2%	-27.1%
% from 52W Low	156.1%	22.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.21x
FCF Yield (TTM)	-22.8%	-10.2%
Earnings Yield (TTM)	-12.5%	-17.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-55.9
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View ENTA research